ProQR Therapeutics News

ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 23 07:09 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 19 07:08 ET

ProQR Therapeutics | 20-F: Registration statement / Annual report / Transition report

Mar 13 08:48 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 13 07:13 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 15 07:52 ET

ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Van Herk Investments B.V.(10.1%),Van Herk Investments THI B.V.(10.1%), etc.

Feb 14 06:13 ET

ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Van Herk Investments B.V.(8.8%),Van Herk Investments THI B.V.(8.8%), etc.

Feb 9 06:39 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 19 00:00 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 5 00:00 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 8, 2023 07:37 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 7, 2023 10:00 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 27, 2023 07:06 ET

ProQR Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Van Herk Investments B.V.(5.3%),Van Herk Investments THI B.V.(5.3%), etc.

Sep 14, 2023 17:20 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 3, 2023 07:15 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 1, 2023 07:15 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 17, 2023 16:05 ET

ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

May 16, 2023 07:15 ET

ProQR Therapeutics | EFFECT: Others

Apr 25, 2023 00:15 ET

ProQR Therapeutics | 424B5: Prospectus

Apr 24, 2023 16:30 ET

ProQR Therapeutics | CORRESP: CORRESP

Apr 20, 2023 16:09 ET